Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2014 1
2018 1
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Transplant-Related Hematologic Malignancy"
Page 1
Single- Versus Double-Unit Umbilical Cord Blood Transplantation for Hematologic Diseases: A Systematic Review.
Wang L, Gu ZY, Liu SF, Ma DX, Zhang C, Liu CJ, Gao R, Guan LX, Zhu CY, Wang FY, Gao CJ, Wei HP. Wang L, et al. Transfus Med Rev. 2019 Jan;33(1):51-60. doi: 10.1016/j.tmrv.2018.11.001. Epub 2018 Nov 6. Transfus Med Rev. 2019. PMID: 30482420
Controversial results exist regarding the clinical benefits of single- vs double-unit umbilical cord blood transplantation (UCBT) in patients with hematologic diseases. A systematic review was conducted to evaluate this issue. ...Double-unit UCBT was associated with higher …
Controversial results exist regarding the clinical benefits of single- vs double-unit umbilical cord blood transplantation (UCBT) in patient …
Impact of HLA-DPB1 Matching on Outcome of Unrelated Transplant for Hematologic Malignant Diseases: A Systematic Review and Meta-analysis.
Wang Y, Xu S, Fang P. Wang Y, et al. Transplant Proc. 2019 Jul-Aug;51(6):1982-1989. doi: 10.1016/j.transproceed.2019.04.053. Transplant Proc. 2019. PMID: 31399180
Comparative studies were carried out to investigate the impact of HLA-DPB1 loci mismatch on clinical outcome after unrelated donor HSCT, that is, the disease-free survival, engraftment, graft-vs-host disease, relapse, and transplant-related mortality (TRM). We perfo …
Comparative studies were carried out to investigate the impact of HLA-DPB1 loci mismatch on clinical outcome after unrelated donor HSCT, tha …
Prophylactic donor lymphocyte infusion for relapse prevention: a meta-analysis.
Poonsombudlert K, Kewcharoen J, Prueksapraopong C, Limpruttidham N. Poonsombudlert K, et al. Jpn J Clin Oncol. 2020 Jun 10;50(6):661-670. doi: 10.1093/jjco/hyaa022. Jpn J Clin Oncol. 2020. PMID: 32100001
OBJECTIVE: Primary disease relapse (PDR) of malignant hematologic conditions after standard hematopoietic stem cell transplant (HSCT) is one of the most challenging diseases; therefore ongoing researches are aiming at relapse prevention and minimizing the transplant …
OBJECTIVE: Primary disease relapse (PDR) of malignant hematologic conditions after standard hematopoietic stem cell transplant (HSCT) …
Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review.
Djulbegovic B, Seidenfeld J, Bonnell C, Kumar A. Djulbegovic B, et al. Cancer Control. 2003 Jan-Feb;10(1):17-41. doi: 10.1177/107327480301000104. Cancer Control. 2003. PMID: 12598853 Free article. Review.
BACKGROUND: Increasingly, clinicians advocate the use of nonmyeloablative allogeneic stem-cell transplants (NM-allo-SCTs, "mini-transplants") to manage hematologic malignancies. They hypothesize that NM-allo-SCT is equally efficacious to standard allo-SCT but produces less …
BACKGROUND: Increasingly, clinicians advocate the use of nonmyeloablative allogeneic stem-cell transplants (NM-allo-SCTs, "mini-transplants" …
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M. Holtick U, et al. Cochrane Database Syst Rev. 2014 Apr 20;2014(4):CD010189. doi: 10.1002/14651858.CD010189.pub2. Cochrane Database Syst Rev. 2014. PMID: 24748537 Free PMC article. Review.
OBJECTIVES: To assess the effect of bone marrow versus peripheral blood stem cell transplantation in adult patients with haematological malignancies with regard to overall survival, incidence of relapse and non-relapse mortality, disease-free survival, transplant-relate …
OBJECTIVES: To assess the effect of bone marrow versus peripheral blood stem cell transplantation in adult patients with haematological mali …